Kimberly Park - 26 Aug 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Director
Issuer ticker: CORT
Reported as of: 26 Aug 2026
Net transaction value: -$3,270,169
SEC form: 4
Accepted by SEC: 28 Aug 2026, 16:30:05 UTC
Prior SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Kimberly Park

Key filing fact

Kimberly Park filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 28 Aug 2026.

Key facts

This page summarizes Kimberly Park's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Aug 2026, 16:30.

Change

Previous filing in this sequence was filed on 26 May 2026.
Current net transaction value: -$3,270,169.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001788208 Primary reporting owner

Park Kimberly

Relationship: Director
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Kimberly Park
Signature date: 28 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Options Exercise

Transaction value
Shares: +30,000
Change %
Price: $13.49^*
Shares after: 30,000
Date: 26 Aug 2026
Ownership: Direct

CORT transaction

Common Stock

Tax liability

Transaction value
Shares: -3,315
Change %: -11%
Price: $122.09^*
Shares after: 26,685
Date: 26 Aug 2026
Ownership: Direct
Footnotes: F1

CORT transaction

Common Stock

Sale

Transaction value: $3,270,169
Shares: -26,685
Change %: -100%
Price: $122.55
Shares after: 0
Date: 26 Aug 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -30,000
Change %: -50%
Price: $0.000000^*
Shares after: 30,000
Date: 26 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $13.49
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were withheld by the Issuer in order to cover the exercise price in connection with the net exercise of stock options reported herein.

Footnote F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $122.50 to $122.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F3

Fully exercisable.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.